ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC)

Clinical trial NCT06182072 · RECRUITING

Trial details

NCT number: NCT06182072
Sponsor: ProDa BioTech, LLC
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Ductal Adenocarcinoma (PDAC)

Start date: 2023-09-14
Primary completion: 2027-06-30
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.